Answers are grounded in this paper and cite their sources.
Derivation of insulin producing cells (IPCs) from embryonic stem (ES) cells provides a potentially innovative form of treatment for type 1 diabetes. Here, we discuss the current state of the art, unique challenges, and future directions on generating IPCs. J. Cell. Physiol. 218: 256–263, 2009. Published 2008 Wiley‐Liss, Inc.
No takes yet. Share an insight, caveat, or question.
Raikwar et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: